Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.17 | 20.21 |
| PEG Ratio (TTM) | -1.97 | -10.51 |
| P/S Ratio (TTM) | 0.63 | 6.87 |
| P/B Ratio (TTM) | 5.84 | 9.88 |
| P/FCF Ratio (TTM) | -15.70 | 44.47 |
| Price to 5YR AVG Earnings Ratio | 24.06 | 27.82 |
| Price to 5YR AVG FCF Ratio | 15.01 | 21.50 |
Profitability (70%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 12.52% | 7.93% |
| ROE (TTM) | 55.30% | 50.16% |
| Net Profit Margin (TTM) | 5.77% | 66.11% |
| ROIC 5YR AVG | 29.74% | 18.49% |
Growth (18%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -3.48% | -19.20% | 9.60% |
| Revenue | 1.77% | 3.21% | 8.35% |
| Net Income | -4.18% | -15.06% | 5.10% |
| Cash Flow | -70.16% | -2,278.17% | -776.49% |
Health (86%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.63 | 1.62 |
| Quick Ratio (TTM) | 1.63 | 1.20 |
| D/E Ratio (TTM) | 1.01 | 2.05 |
| Interest Coverage (TTM) | 12.22 | 6.36 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 4.11 | 3.51 |
| LTL to 5YR AVG FCF | 2.90 | 3.99 |
| Shares Outstanding Growth 5YR AVG | -7.32% | -1.19% |